Fresenius reported €22.14B in Loan Capital for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Akzo Nobel AKZA:NA 2B 761M
Alcon AG ALC:SW 4.3B 8M
AstraZeneca AZN:LN 28939M 4338M
BASF BAS:GR € 15092M 138M
Bayer BAYN:GR € 36974M 310M
Davita Healthcare Partners DVA:US $ 8770.88M 27.38M
DSM DSM:NA € 3479M 30M
E.ON EOAN:GR 30.37B 493M
Fresenius FRE:GR € 22142M 127M
Fresenius Medical Care FME:GR € 10570M 100.97M
Fresenius Medical Care FMS:US $ 10570M 100.97M
Getinge GETIB:SS 5.56B 562M
Givaudan GIVN:VX 4.31B 61M
GlaxoSmithKline GSK:LN 20736M 294M
GN Store Nord GN:DC 5.76B 12M
GRIFOLS GRF:SM € 6978M 247.04M
Hikma Pharmaceutical HIK:LN 751M 13M
Lonza Group LONN:SW 2.79B 5M
Merck MRK:GR € 8195M 526M
Novartis NOVN:VX SF 24715M 1776M
Philips PHIA:NA € 6623M 741M
RWE RWE:GR € 5214M 243M
William Demant Holding WDH:DC 4.96B 26M